Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulinastatin for lower extremity ischemia-reperfusion injury after total knee replacement
ChiCTR-TRC-11001473Phase 4Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of ulinastatin in ischemia-reperfusion injury (IRI) and postoperative pain (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: Inflammation factors, Intraoperative hemodynamics and 3 more. Started Jan 2011; status: completed.
02
Drugs
ulinastatin
03
Conditions
ischemia-reperfusion injury (IRI)postoperative pain
Beyond the preview
Go deeper on ChiCTR-TRC-11001473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001473.